Small-Cap REIT ETF ...
Health Care: Drugs
Regeneron Pharmaceuticals Inc. (REGN: NASDAQ)
$266.97 2.31 | 0.87%
05/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:36.35
Price Earnings Comparisons:
| REGN | Sector Avg. | S&P 500 |
|---|---|---|
| 36.35 | 36.50 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 66.20 | 101.88 | 901.50 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 209.20 | 2.63 | 0.53 |
| Net Income | -12.06 | 0.00 | |
| EPS | -10.32 | 0.00 |
Earnings for REGN:
| EBITDA | 494.65M |
| REVENUE | 1.38B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.04 | $1.11 | $3.60 | $6.54 |
| Number of Analysts | 7 | 6 | 7 | 9 |
| High Estimate | $1.72 | $1.50 | $4.90 | $11.82 |
| Low Estimate | $0.72 | $0.83 | $2.59 | $3.82 |
| Prior Year | $0.75 | $1.77 | $n.a. | $3.60 |
| Growth Rate (Year over Year) | 38.29% | -37.29% | n.a.% | 82.01% |
Portfolios with REGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- Contributor10 Companies That Prove Sto...
- ContributorDrugs Facing FDA Approval i...
- ContributorEarnings Short Squeeze Play...
- Contributor10 Stocks of Top-Performing...
- ContributorEarnings Short Squeeze Play...
- ContributorRelative Strength Trades fo...
- Contributor10 Stocks That Boosted Firs...
Latest REGN Headlines from TheStreet
- Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard 05.15.13 | 05:05 pm
- 3 Stocks Underperforming Today In The Drugs Industry 05.15.13 | 01:05 pm
- Cramer's 'Mad Money' Recap: Stick With What Works 05.14.13 | 08:05 pm
- Cramer's 6 Stocks in 60 Seconds: MNST CLX REGN KR MDRX PG (Update 1) 05.14.13 | 05:05 pm
- Cramer: Biotech Makes a Comeback 05.10.13 | 04:05 pm
- Regeneron Stock Hits New 52-Week High (REGN) 05.10.13 | 11:05 am
- Biotech Is Where the Bucks Are 05.09.13 | 06:05 am
- Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN) 05.08.13 | 10:05 am
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner 05.03.13 | 05:05 pm
Press Releases for REGN
- BioMed Realty To Develop 297,000 Square Feet In New York Fully Leased To Regeneron Pharmaceuticals - PR Newswire 04.04.13 | 09:04 am
- Regeneron Named World's #1 Biopharmaceutical Employer In Science Magazine Annual Survey - PR Newswire 09.21.12 | 12:09 pm
- Sanofi And Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody - PR Newswire 07.20.12 | 01:07 am
- Sanofi And Regeneron Announce Publication Of Positive Phase 2 Results For Lipid-Lowering PCSK9 Antibody In The Lancet - PR Newswire 05.26.12 | 11:05 am
- Sanofi And Regeneron Announce Regulatory And Clinical Update For ZALTRAP® (aflibercept) - PR Newswire 04.05.12 | 01:04 am
- Sanofi And Regeneron Report Phase 2 Data For Potential First-in-Class Lipid-Lowering PCSK9 Antibody - PR Newswire 03.26.12 | 11:03 am
- Regeneron And Bayer Announce Approval Of EYLEA® (aflibercept) Injection For The Treatment Of Wet Age-Related Macular Degeneration In Australia - PR Newswire 03.08.12 | 04:03 am
- Two Year Results Of Phase 3 Studies With EYLEA⢠(aflibercept) Injection In Wet AMD Show Sustained Improvement In Visual Acuity - PR Newswire 12.05.11 | 02:12 am
- Regeneron And Bayer Initiate Phase 3 Clinical Program For The Treatment Of Wet Age-Related Macular Degeneration In China - PR Newswire 11.28.11 | 02:11 am
- Phase 3 Trial Of ZALTRAP⢠(aflibercept) In Advanced Prostate Cancer To Continue As Planned At Recommendation Of Independent Data Monitoring Committee - PR Newswire 07.07.11 | 07:07 am
Partner Headlines for REGN
- Alkermes Leaps On Study Results, May Offer New Entry - Investor's Business Daily 04.17.13 | 05:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,264.63 up 48.14 points - NASDAQ 04.16.13 | 08:04 pm
- Indexes Finish With Solid Gains; After Hours Heats Up - Investor's Business Daily 04.16.13 | 05:04 pm
- Stocks Hold Near Highs; Regeneron Shoots To New Peak - Investor's Business Daily 04.16.13 | 03:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Regeneron's Flagship Drug Treats Blindness In Seniors - Investor's Business Daily 04.11.13 | 05:04 pm
- Buyers Put Money To Work; Dow, S&P 500 Touch Highs - Investor's Business Daily 04.09.13 | 04:04 pm
- Stocks Flat As Early Gains Fade; Regeneron Hits New High - Investor's Business Daily 04.09.13 | 10:04 am
- IBD Big Cap 20 Analysis: Some Stocks Show Resilience - Investor's Business Daily 04.08.13 | 06:04 pm
